Medi-Hut Announces a New Safety Engineered Medical Device Product.

Business Editors

Joseph A. Sanpietro, President and CEO of Medi-Hut (NASDAQ SC: MHUT) announced "Medi-Hut has signed an Exclusive License Agreement for a patented safety engineered IV Catheter system that greatly reduces the risk of an accidental needle stick every time it is used.

The catheter market in the U.S. was reported to be 261 million units or $340-588 million during 2000. We believe our patented catheter will capture a significant percentage of the market and positively add to Medi-Hut's revenues and net income for years to come."

The uniquely designed `closed-hub' (sealed) patented safety catheter we feel is easier to use than any other safety catheter in the marketplace, is totally responsive to the needs and concerns of healthcare workers, and is the only safety engineered catheter incorporating all of these features:

-- Automatic needle protection

-- Bloodless IV starts

-- Built-in optional Heparin/Saline lock

-- Revolutionary new flash chamber

-- Simplified training

-- Sterile cannulations assured

-- Safe and easy blood draws/samples

-- Additional proximal injection port

-- Optimized design features including no looping, better sensitivity, easier injections etc.

-- Additional automatic safety features include preventing blood regurgitation/improves sterility

-- Improved IV success rates

Mr. Sanpietro concluded "Medi-Hut wants to bring this uniquely designed and patented safety catheter to the marketplace and add it to the safety engineered product line we currently offer. Medi-Hut will begin the 510K process and then bring the patented catheter through the manufacturing process and into the marketplace as quickly as possible."

Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21 E of the Securities Exchange Act of 1934, and as that term defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. Since these statements involve risks and uncertainties and are subject to change at any time, the Company's actual results could differ materially from expected results.